Efficacy of dendritic cell-based immunotherapy produced from cord blood in vitro and in a humanized NSG mouse cancer model
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of dendritic cell-based immunotherapy produced from cord blood in vitro and in a humanized NSG mouse cancer model
Authors
Keywords
-
Journal
Immunotherapy
Volume 11, Issue 7, Pages 599-616
Publisher
Future Medicine Ltd
Online
2019-04-04
DOI
10.2217/imt-2018-0103
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection of endogenously circulating Mesenchymal Stem Cells in human cancer patients
- (2018) Daphne L. van der Velden et al. INTERNATIONAL JOURNAL OF CANCER
- Virus-Specific CD8+T Cells Infiltrate Melanoma Lesions and Retain Function Independently of PD-1 Expression
- (2017) Dan A. Erkes et al. JOURNAL OF IMMUNOLOGY
- Hematopoietic stem cell-derived myeloid and plasmacytoid DC-based vaccines are highly potent inducers of tumor-reactive T cell and NK cell responses ex vivo
- (2017) Soley Thordardottir et al. OncoImmunology
- Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas
- (2016) M. S. Merchant et al. CLINICAL CANCER RESEARCH
- NK Cell Activation in the Antitumor Response Induced by IFN-α Dendritic Cells Loaded with Apoptotic Cells from Follicular Lymphoma Patients
- (2016) Caterina Lapenta et al. JOURNAL OF IMMUNOLOGY
- Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results
- (2016) Phuc Van Pham et al. OncoTargets and Therapy
- Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study
- (2015) Akira Kawai et al. LANCET ONCOLOGY
- Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial
- (2015) Giovanni Grignani et al. LANCET ONCOLOGY
- Microenvironmental regulation of therapeutic response in cancer
- (2015) Florian Klemm et al. TRENDS IN CELL BIOLOGY
- Immunological response and overall survival in a subset of advanced renal cell carcinoma patients from a randomized phase 2/3 study of naptumomab estafenatox plus IFN-α versus IFN-α
- (2015) Eyad Elkord et al. Oncotarget
- Antigenically Modified Human Pluripotent Stem Cells Generate Antigen-Presenting Dendritic Cells
- (2015) Jieming Zeng et al. Scientific Reports
- Umbilical cord blood-derived CD11c+ dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy
- (2015) Jeetendra Kumar et al. Stem Cell Research & Therapy
- Human tumor infiltrating lymphocytes cooperatively regulate prostate tumor growth in a humanized mouse model
- (2015) Michael D Roth et al. Journal for ImmunoTherapy of Cancer
- Tumor cell lysates as immunogenic sources for cancer vaccine design
- (2015) Fermín E González et al. Human Vaccines & Immunotherapeutics
- RIG-I Helicase-Independent Pathway in Sendai Virus-Activated Dendritic Cells Is Critical for Preventing Lung Metastasis of AT6.3 Prostate Cancer
- (2015) Tomonori Kato et al. NEOPLASIA
- HIV Infection Accelerates Gastrointestinal Tumor Outgrowth in NSG-HuPBL Mice
- (2014) Rong Lu et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis
- (2014) Masanori Kobayashi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma
- (2013) Xiaodan Chen et al. AUTOIMMUNITY
- Booster Vaccinations against Cancer Are Critical in Prophylactic but Detrimental in Therapeutic Settings
- (2013) A. Ricupito et al. CANCER RESEARCH
- Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies
- (2013) Pawel Kalinski et al. Expert Review of Vaccines
- Dendritic-Cell-Based Therapeutic Cancer Vaccines
- (2013) Karolina Palucka et al. IMMUNITY
- Potential Limitations of the NSG Humanized Mouse as a Model System to Optimize Engineered Human T cell Therapy for Cancer
- (2013) Erik M. Alcantar-Orozco et al. Human Gene Therapy Methods
- Dendritic Cells in the Cancer Microenvironment
- (2013) Yang Ma et al. Journal of Cancer
- Harnessing human plasmacytoid dendritic cells as professional APCs
- (2012) Jurjen Tel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma
- (2012) Nourredine Himoudi et al. Clinical & Translational Oncology
- Cord blood stem-cell-derived dendritic cells generate potent antigen-specific immune responses and anti-tumour effects
- (2012) Ming-Cheng Chang et al. CLINICAL SCIENCE
- NOD/scid IL-2Rgnull mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo
- (2012) Stefani Spranger et al. Journal of Translational Medicine
- CD86 and IL-12p70 Are Key Players for T Helper 1 Polarization and Natural Killer Cell Activation by Toll-Like Receptor-Induced Dendritic Cells
- (2012) Felix S. Lichtenegger et al. PLoS One
- Engineering Dendritic Cells to Enhance Cancer Immunotherapy
- (2011) Jeanette E Boudreau et al. MOLECULAR THERAPY
- Cytokine-based high log-scale expansion of functional human dendritic cells from cord-blood CD34-positive cells
- (2011) Yui Harada et al. Scientific Reports
- A Randomized Trial of Ex vivo CD40L Activation of a Dendritic Cell Vaccine in Colorectal Cancer Patients: Tumor-Specific Immune Responses Are Associated with Improved Survival
- (2010) R. J. Barth et al. CLINICAL CANCER RESEARCH
- Designing Vaccines Based on Biology of Human Dendritic Cell Subsets
- (2010) Karolina Palucka et al. IMMUNITY
- Generation of Th1-Polarizing Dendritic Cells Using the TLR7/8 Agonist CL075
- (2010) S. Spranger et al. JOURNAL OF IMMUNOLOGY
- Reconstitution of huPBL-NSG Mice with Donor-Matched Dendritic Cells Enables Antigen-Specific T-cell Activation
- (2010) Airi Harui et al. Journal of Neuroimmune Pharmacology
- Three-day dendritic cells for vaccine development: Antigen uptake, processing and presentation
- (2010) Maja Bürdek et al. Journal of Translational Medicine
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- A large number of mature and functional dendritic cells can be efficiently generated from umbilical cord blood-derived mononuclear cells by a simple two-step culture method
- (2010) Sreekumar Balan et al. TRANSFUSION
- Immune Therapy for Cancer
- (2008) Michael Dougan et al. Annual Review of Immunology
- Complete elimination of established neuroblastoma by synergistic action of γ-irradiation and DCs treated with rSeV expressing interferon-β gene
- (2008) K Tatsuta et al. GENE THERAPY
- Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies
- (2008) Shin-ichiro Fujii TRENDS IN IMMUNOLOGY
- Immunotherapy with dendritic cells for cancer
- (2007) Alberto Ballestrero et al. ADVANCED DRUG DELIVERY REVIEWS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started